Amgen, Inc. (AMGN)
336.39
+0.33
(+0.10%)
USD |
NASDAQ |
May 28, 16:00
336.39
0.00 (0.00%)
After-Hours: 17:28
Amgen Research and Development Expense (Annual) : 6.974B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Biogen, Inc. | 1.481B |
| Gilead Sciences, Inc. | 5.688B |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| AbbVie, Inc. | 8.249B |
| Moderna, Inc. | 2.917B |